CoChat

Oxidation of Acetaminophen to Its Toxic Quinone Imine and Nontoxic Catechol Metabolites by Baculovirus-Expressed and Purified Human Cytochromes P450 2E1 and 2A6

The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.

Abstract

Acetaminophen (APAP), a widely used analgesic and antipyretic agent, is bioactivated by cytochromes P450 to cause severe hepatotoxicity. APAP is oxidized by two pathways to form a toxic intermediate, N-acetyl-p-benzoquinone imine (NAPQI), and a nontoxic catechol metabolite, 3-hydroxy-APAP (3-OH-APAP). We investigated the role of P450 2E1 and 2A6 in APAP oxidation by using baculovirus-expressed and highly purified forms of human P450 2E1 and 2A6. An electrochemical HPLC assay was developed to quantify both oxidative metabolites simultaneously. For the first time, it was demonstrated that human P450 2E1 selectively oxidized APAP to NAPQI (assayed as its glutathione conjugate, GS-APAP), whereas human P450 2A6 selectively oxidized APAP to 3-OH-APAP. At 1 mM APAP, the relative ratio for the formation of GS-APAP vs 3-OH-APAP with human P450 2E1 was approximately 6:1, whereas the ratio with human P450 2A6 was 1:3. Apparent Km and Vmax values for the formation of GS-APAP by human P450 2E1 were 1.3 mM and 6.9 nmol/min/nmol of P450, respectively, whereas they were 4.6 mM and 7.9 nmol/min/nmol of P450 for P450 2A6. Apparent Km and Vmax values for the formation of 3-OH-APAP by human P450 2E1 were 4.0 mM and 2.5 nmol/min/nmol of P450, respectively, whereas they were 2.2 mM and 14.2 nmol/min/nmol of P450, respectively, for P450 2A6. Thus, although at toxic doses of APAP P450 2E1 is the more efficient catalyst for the formation of the toxic metabolite NAPQI, P450 2A6 also can contribute significantly to NAPQI production.

Overview

Integrity signals

Registry

Crossref · 10.1021/tx9701687

Cites

14 of 14 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Research works printed but not linked: 36

  1. Hinson J. A., 1980, Rev. Biochem. Toxicol., 12
  2. Nelson S. D., 1990, Molecular mechanisms of the hepatotoxicity caused by acetaminophen. Semin. Liver Disease 10, 267−278
  3. Vermeulen N. P. E., 1992, Drug Metab. Rev., 24
  4. Prescott, L. F. (1996)Paracetamol(Acetaminophen)aCriticalBibliographicReview, pp 285−351, Taylor & Francis Ltd., London.
  5. Mitchell J. R., 1973, J. Pharmacol. Exp. Ther., 187
  6. Potter W. Z., 1973, J. Pharmacol. Exp. Ther., 187
  7. Corcoran G. B., 1984, N-acetyl-p-benzoquinone imine. Mol. Pharmacol. 18, 536−542.
  8. Dahlin D. C., 1984, Proc. Natl. Acad. Sci. U.S.A. 81
  9. Hinson J. A., 1980, 3-Hydroxyacetaminophen: A microsomal metabolite of acetaminophen. Drug Metab. Dispos. 8, 289−294
  10. Forte A. J., 1984, The formation and toxicity of catechol metabolites of acetaminophen in mice. Drug Metab. Dispos. 12, 484−491
  11. Guengerich F. P., 1991, Role of human cytochrome P-450 IIE1 in the oxidation of many low molecular weight cancer suspects. Chem. Res. Toxicol. 4, 168−179
  12. Raucy J. L., 1989, Acetaminophen activation by human liver cytochromes P450IIE1 and P450IA2. Arch. Biochem. Biophys. 271, 270−283
  13. Patten C. J., 1993, Cytochrome P450 enzymes involved in acetaminophen activation by rat and human liver microsomes and their kinetics. Chem. Res. Toxicol. 6, 511−518
  14. Lee S. S.-T., 1996, J. Biol. Chem., 271
  15. Burk R. F., 1990, Isoniazid potentiation of acetaminophen hepatotoxicity in the rat and 4-methylpyrazole inhibition of it. Res. Commun. Chem. Pathol. Pharmacol. 69, 115−118
  16. Guengerich, F. P. (1995) InCytochromeP450:Structure,Mechanism,andBiochemistry, 2nd ed. (Ortiz de Montellano, P. R., Ed.) Chapter 14, p 485, Plenum Press, New York.
  17. Yamano S., 1990, The CYP2A3 gene product catalyzes coumarin 7-hydroxylation in human liver microsomes. Biochemistry 29, 1322−1329
  18. Yamazaki H., 1992, Cytochrome P450 2E1 and 2A6 enzymes as major catalysts for metabolic activation of N-nitrosodialkylamines and tobacco-related nitrosamines in human liver microsomes. Carcinogenesis 13, 1789−1794
  19. Duescher R. J., 1994, Human liver microsomes are efficient catalysts of 1,3-butadiene oxidation: Evidence for major roles by cytochrome P450 2A6 and 2E1. Arch. Biochem. Biophys. 311, 342−349
  20. Zhou L., 1997, J. Pharmacol. Exp. Ther., 281
  21. Chen W., 1996, Baculovirus expression and purification of human and rat cytochrome P450 2E1. Arch. Biochem. Biophys. 335, 123−130
  22. Thompson S. J., 1997, Baculovirus mediated expression, purification, and catalytic activity of human CYP2A6. Toxicologist 36 (Abstract 109), 22
  23. Shen A. L., 1991, J. Biol. Chem., 266
  24. Thummel K. E., 1993, Human liver microsomal enflurane defluorination catalyzed by cytochrome P-450 2E1. Drug Metab. Dispos. 21, 350−357
  25. Koenigs L. L., 1997, Mechanism-based inactivation of human liver cytochrome P450 2A6 by 8-methoxypsoralen. Drug Metab. Dispos. 25, 1407−1415
  26. Patten C. J., 1992, Catalytic properties of the human cytochrome P450 2E1 produced by cDNA expression in mammalian cells. Arch. Biochem. Biophys. 299, 163−171
  27. Peter R., 1990, Hydroxylation of chlorzoxazone as a specific probe for human liver cytochrome P-450IIE1. Chem. Res. Toxicol. 3, 566−573
  28. Wilkinson L., 1987, SYSTAT: The system for statistics
  29. Koop D. R., 1986, Hydroxylation of p-nitrophenol by rabbit ethanol-inducible cytochrome P-450 isozyme 3a. Mol. Pharmacol. 29, 399−404
  30. Levin W., 1986, N-Demethylation of N-nitrosodimethylamine catalyzed by purified rat hepatic microsomal cytochrome P-450: isozyme specificity and role of cytochrome b5. Arch. Biochem. Biophys. 248, 158−165
  31. Myers T. G., 1995, A comparative study of mouse liver proteins arylated by reactive metabolites of acetaminophen and its nonhepatotoxic regioisomer, 3‘-hydroxyacetanilide. Chem. Res. Toxicol. 8, 403−411
  32. Halmes N. C., 1996, ISSX Proc., 10, 76
  33. Rumack B. H., 1978, Acetaminophen overdose: Incidence, diagnosis and management in 416 patients. Pediatrics 62, 898−903
  34. Ramsay R. P., 1989, vitro effects of acetaminophen metabolites and analogues on the respiration of mouse liver mitochondria. Arch. Biochem. Biophys. 273, 449−457
  35. Myers T. G., 1994, J. Med. Chem., 37
  36. Abbreviations APAP, acetaminophen

Cited by

See all 250

Metadata

Authors
Chen, W., Koenigs, L. L., Thompson, S. J., Peter, R. M., Rettie, A. E., Trager, W. F., & Nelson, S. D.
Affiliations
University of Washington (US)
Venue
Chemical Research in Toxicology
Published
1998-02-27
Volume
11
Issue
4
Pages
295-301
ISSN
  • 0893-228X (ISSN-L)
  • 1520-5010
OpenAlex
W2050204181
Cited by
226
References
14
Citations by year
2026: 6 · 2025: 8 · 2024: 2 · 2023: 7 · 2022: 5 · 2021: 6 · 2020: 9 · 2019: 11 · 2018: 12 · 2017: 7 · 2016: 10 · 2015: 13 · 2014: 8 · 2013: 8 · 2012: 10
FWCI
3.87
Type
journal article
Language
en
Open access
closed
Locations
  • Chemical Research in Toxicology (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Institute of General Medical Sciences (R01GM049054, GM32165, P01GM032165, GM49054)
Topics
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Bioactive Compounds and Antitumor Agents
Keywords
paracetamol, N-acetyl-p-benzoquinone imine, CYP2E1, CYP2A6, hepatotoxicity, glutathione conjugates, enzyme kinetics, substrate specificity
MeSH terms
Acetaminophen, Aryl Hydrocarbon Hydroxylases, Cytochrome P-450 Enzyme System, Humans, Mixed Function Oxygenases, Baculoviridae, Analgesics, Non-Narcotic, Cytochrome P-450 CYP2E1, Cytochrome P-450 CYP2A6

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.